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Highlights 
 
x Nanomedicines can improve the precise delivery of therapeutics 
x PDT and PTT can be efficiently delivered through nanomedicines 
x Further investigation is crucial for clinical translation 
 
 
 
Dear Editor, 
We have read with great interest, the recently published article by Vivek et al. (2018), 
GHVFULELQJWKHDXWKRUV¶UHVHDUFKRQWKHWKHUDSHXWLFDSSOLFDWLRQVRIDPXOWLIXQFWLRQDO
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nanomedicine [1]. This paper discusses the combined efficacy of photodynamic 
therapy (PDT), photothermal therapy (PTT) and carboplatin (CBP) chemotherapy, 
using CBP and indocyanine green (ICG) loaded nanoparticles (NPs), functionalised 
with polyethylene glycol and folic acid. Significant uptake and retention of NPs in vitro, 
was observed in the folate receptor-overexpressing breast cancer cell line, MCF7. The 
intracellular acidic pH environment of cancer cells induced the release of therapeutic 
agents into the cytoplasm. Upon near-infrared light irradiation, the increase in 
intracellular temperature and simultaneous increasing production of reactive oxygen 
species, was attributed to the photothermal conversion and photodynamic properties 
of ICG respectively [2]. The dual synergistic effect of PDT and PTT resulted in an 
apoptotic cell death. Furthermore, significant regression in tumour growth with no 
noticeable adverse effects, was observed in animal models treated with NPs and near-
infrared light irradiation. 
This study is a good example of the rapid growing interest in multifunctional anti-
cancer nanomedicines, combining PDT, PTT and conventional chemotherapy. We 
recently reviewed the scope of photothermal therapy-based nanomedicines, in 
colorectal cancers and highlight the diverse combinations of phototherapeutic, 
chemotherapeutic, optical imaging and cancer-targeting nanomedicines that have 
been investigated in the past decade [3]. These nanomedicines have shown to 
significantly improve the management of solid colorectal cancers, by efficiently 
packaging different treatment methods into a single entity. 
Unlike the study by Vivek et al. (2018) which demonstrated both PTT and PDT through 
ICG [1]. Seo et al. (2014) synthesised and evaluated PTT and PDT using NPs 
comprised of gold nanorods (to induce PTT) and methylene blue (to induce PDT) [4]. 
The authors successfully show synergy between PDT and PTT, in comparison to PDT 
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or PTT alone. The aforementioned studies, demonstrate the flexibility in customising 
PTT and PDT inducing NPs, using different types of photosensitising agents. 
Thus far, many novel multimodal PDT and/or PTT nanomedicines have been the 
subject of µSURRI-of-SULQFLSOH¶pre-clinical studies, showing potential clinical applications. 
Currently, PDT and PTT (through thermal ablation) are utilised in clinics to treat 
cancers and both techniques have independently proven to be successful as stand-
alone methods and in combination with more conventional means of treatment [5,6]. 
However, due to the apparent lack of controlled and randomised clinical trials 
investigating phototherapy nanomedicines, it is difficult to design appropriate clinical 
protocols and identify key candidates for further evaluation and clinical translation. 
Nevertheless, the remarkable progression in this field with a focus on precision 
medicine means that the clinical application of phototherapy nanomedicines is feasible 
in the near future. 
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